Results 191 to 200 of about 924,459 (214)
Improving Diagnostic Precision: Phenotype-Driven Analysis Uncovers a Maternal Mosaicism in an Individual with RYR1-Congenital Myopathy. [PDF]
Estévez-Arias B +15 more
europepmc +1 more source
Prevalence and phenotypes of congenital myopathy due to α-actin 1 gene mutations
INTRODUCTION: Congenital myopathy due to mutations in the α-actin 1 gene (ACTA1) was identified in 1999, but knowledge of prevalence and phenotype in patients who survive 5 years is lacking.METHODS: A national cohort of 91 patients aged ≥5 years and ...
John Vissing +2 more
exaly +3 more sources
Novel SPEG Mutations in Congenital Myopathy without Centralized Nuclei
Congenital myopathies are clinically and genetically heterogeneous, and are classified based on typical structural abnormalities on muscle sections. Recessive mutations in the striated muscle preferentially expressed protein kinase (SPEG) were recently ...
X. Lornage +10 more
semanticscholar +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
STAC3 related congenital myopathy: A case series of seven Comorian patients.
European Journal of Medical Genetics, 2022The Bailey-Bloch congenital myopathy, also known as Native American myopathy (NAM), is an autosomal recessive congenital myopathy first reported in the Lumbee tribe people settled in North Carolina (USA), and characterized by congenital weakness and ...
Marie Gromand +9 more
semanticscholar +1 more source
RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine
Neuromuscular Disorders, 2014S A Robb, A Manzur, S A Robb
exaly +2 more sources
Biallelic loss‐of‐function HACD1 variants are a bona fide cause of congenital myopathy
Clinical Genetics, 2020Congenital myopathies include a wide range of genetically determined disorders characterized by muscle weakness that usually manifest shortly after birth. To date, two different homozygous loss‐of‐function variants in the HACD1 gene have been reported to
L. Abbasi-Moheb +9 more
semanticscholar +1 more source
European Journal of Neurology, 2020
Congenital muscular dystrophies (CMDs) and congenital myopathies (CMs) are a group of genetically and clinically heterogeneous degenerative primary muscle disorders with onset at birth or during infancy.
S. Sanga +15 more
semanticscholar +1 more source
Congenital muscular dystrophies (CMDs) and congenital myopathies (CMs) are a group of genetically and clinically heterogeneous degenerative primary muscle disorders with onset at birth or during infancy.
S. Sanga +15 more
semanticscholar +1 more source
Congenital Muscular Dystrophy and Congenital Myopathy.
Continuum, 2019PURPOSE OF REVIEW Congenital muscular dystrophies and congenital myopathies are a heterogeneous group of disorders resulting in hypotonia, muscle weakness, and dystrophic or myopathic features on muscle biopsy.
R. Butterfield
semanticscholar +1 more source
Novel TUBA4A variant causes congenital myopathy with focal myofibrillar disorganisation
Journal of Medical GeneticsBackground Congenital myopathies are a clinical, histopathological and genetic heterogeneous group of inherited muscle disorders that are defined on peculiar architectural abnormalities in the muscle fibres. Although there have been at least 33 different
Y.S. Wan +13 more
semanticscholar +1 more source

